ADAGE Capital Partners Gp, LLC, 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 2,153,004 shares at $68.13 ($163.4M) on 2017-05-24, disclosed to the SEC on 2017-05-26.
Open-market sale of $163.4M PBYI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.13 | 50,000 | $3.4M | 2.1% |
| 2 | $69.00 | 39,115 | $2.7M | 1.7% |
| 3 | $70.31 | 53,600 | $3.8M | 2.3% |
| 4 | $72.22 | 52,300 | $3.8M | 2.3% |
| 5 | $73.29 | 175,687 | $12.9M | 7.9% |
| 6 | $73.29 | 175,687 |
| $12.9M |
| 7.9% |
| 7 | $74.49 | 48,865 | $3.6M | 2.2% |
| 8 | $74.49 | 48,865 | $3.6M | 2.2% |
| 9 | $75.00 | 116,133 | $8.7M | 5.3% |
| 10 | $76.91 | 85,526 | $6.6M | 4.0% |
| 11 | $76.91 | 85,526 | $6.6M | 4.0% |
| 12 | $77.61 | 232,190 | $18.0M | 11.0% |
| 13 | $77.61 | 232,190 | $18.0M | 11.0% |
| 14 | $78.25 | 7,248 | $567K | 0.3% |
| 15 | $79.70 | 75,036 | $6.0M | 3.7% |
| 16 | $79.70 | 75,036 | $6.0M | 3.7% |
| 17 | $76.72 | 187,847 | $14.4M | 8.8% |
| 18 | $76.72 | 187,847 | $14.4M | 8.8% |
| 19 | $77.66 | 111,823 | $8.7M | 5.3% |
| 20 | $77.66 | 111,823 | $8.7M | 5.3% |
| 21 | $78.35 | 330 | $26K | 0.0% |
| 22 | $78.35 | 330 | $26K | 0.0% |
| Total | $75.88 avg | 2,153,004 | $163.4M | 100% |
| Filing → |
| GCMG | BUY | 2021-07-13 | $4.3M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $8.6M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $1.5M | — | Filing → |